These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10146127)

  • 41. The case for integrated delivery systems.
    Guttler SD
    N Engl J Med; 2010 Jan; 362(1):86; author reply 86. PubMed ID: 20054055
    [No Abstract]   [Full Text] [Related]  

  • 42. Federal tax concerns in structuring integrated delivery systems. Part II: Systems with taxable and tax-exempt participants.
    Ing E
    Med Interface; 1995 Sep; 8(9):110-2, 114. PubMed ID: 10151602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How intermediate sanctions change the dynamics of healthcare transactions.
    Davidson DM; Wester J
    Healthc Financ Manage; 1997 Jul; 51(7):60-1. PubMed ID: 10168440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hospital-physician arrangements: the new IRS position.
    Leech JD
    Trustee; 1992 May; 45(5):8-9, 23. PubMed ID: 10117824
    [No Abstract]   [Full Text] [Related]  

  • 45. Antitrust issues facing multiprovider networks.
    Ettinger DA; Berenbaum SP
    J Health Hosp Law; 1996; 29(1):30-7, 48. PubMed ID: 10160171
    [No Abstract]   [Full Text] [Related]  

  • 46. Limits placed on PHOs by antitrust rulings, transitional structure for integration.
    Health Care Strateg Manage; 1995 Nov; 13(11):14-5. PubMed ID: 10151858
    [No Abstract]   [Full Text] [Related]  

  • 47. Physician contracts audits: a hospital management tool.
    Jeddeloh NP
    J Health Hosp Law; 1988 May; 21(5):105-12. PubMed ID: 10287908
    [No Abstract]   [Full Text] [Related]  

  • 48. ACOs and the enforcement of fraud, abuse, and antitrust laws.
    Leibenluft RF
    N Engl J Med; 2011 Jan; 364(2):99-101. PubMed ID: 21175308
    [No Abstract]   [Full Text] [Related]  

  • 49. Miscellaneous legal issues affecting integrated delivery systems, foundations, and management services organizations.
    Owens JF
    Top Health Care Financ; 1994; 20(3):61-9. PubMed ID: 8191497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The minefield after Marshfield: how to avoid antitrust violations.
    Caesar NB
    Manag Care; 1995 Aug; 4(8):40-5. PubMed ID: 10145014
    [No Abstract]   [Full Text] [Related]  

  • 51. Antitrust issues for medical groups.
    Gamma F
    Coll Rev; 1992; 9(1):48-82. PubMed ID: 10118929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Joint ventures and illegal remuneration: the pressure is growing.
    Sax BM
    Healthc Financ Manage; 1986 Mar; 40(3):38-41. PubMed ID: 10275451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accountable care and integration: a challenge for credentialing and risk management.
    Barr SM; Mattioli ML
    J Healthc Risk Manag; 2014; 34(1):28-36. PubMed ID: 25070254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Restrictions on depreciation where tax-exempt entities are involved.
    Beggan JF; McNulty LK
    Top Health Care Financ; 1991; 18(1):62-9. PubMed ID: 1949005
    [No Abstract]   [Full Text] [Related]  

  • 55. Physician joint ventures: new opportunities and risks.
    Miller JN
    J Med Pract Manage; 2004; 19(6):292-5. PubMed ID: 15293656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protecting the hospital's physician recruitment program.
    Bromberg RS
    Healthc Financ Manage; 1986 Oct; 40(10):62-4, 70-2. PubMed ID: 10278537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tax-exempt integrated delivery systems: Part 1, Federal anti-kickback laws.
    Vogel PL; Cripps HM
    Mo Med; 1995 Jul; 92(7):324-6. PubMed ID: 7651308
    [No Abstract]   [Full Text] [Related]  

  • 58. How PHOs can avoid price-fixing charges.
    Ettinger DA
    Healthc Financ Manage; 1996 Jul; 50(7):72-6. PubMed ID: 10158698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Legally speaking: Federal Trade Commission issues positive advisory opinions on antitrust implications of clinical integration.
    Wright R
    J Ark Med Soc; 2009 Oct; 106(4):88-9. PubMed ID: 19813398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognosis: prison? Health care providers, as they set up new business arrangements in this era of rising medical costs, risk running afoul of federal antitrust and antifraud laws.
    Kosterlitz J
    Natl J (Wash); 1989 Jun; 21(24):1576-7, 1582-4. PubMed ID: 10293560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.